Tanja Fauti

Next-generation insights into regulatory T cells: expression profiling and FoxP3 occupancy in Human

D. Mennerich, M. Lenter, F. Birzele, 2011, Nucleic acids research.

Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab In Vitro and in Xenograft Models

C. Klein, M. Bacac, C. Dumontet, 2013, Molecular Cancer Therapeutics.

Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab In Vitro and in Xenograft Models

C. Klein, M. Bacac, C. Dumontet, 2013, Molecular Cancer Therapeutics.

Application of a MABEL Approach for a T-Cell-Bispecific Monoclonal Antibody: CEA TCB

C. Klein, T. Singer, M. Bacac, 2016, Journal of immunotherapy.

Pharmacokinetics and Pharmacodynamics of T-Cell Bispecifics in the Tumour Interstitial Fluid

C. Klein, M. Bacac, A. Walz, 2021, Pharmaceutics.